Delic Holdings Corp’s (CSE: DELC) (OTCQB: DELCF) Co-Founder and CEO Offers a Glimpse into the Company’s History and Future on The Jesse Tee Show

• While appearing on The Jesse Tee Show, the company’s co-founder and CEO, Matt Stang, shared his professional background, Delic’s history, its growth, and its plans going forward
• Mr. Stang attributes its success to understanding where opportunities and people connect, how to make things win-win for all people, and giving customers value
• Founded in 2016, Delic Holdings Corp now has a market cap of $4.32 million as of March 2022

Delic Holdings (CSE: DELC) (OTCQB: DELCF) has been at the forefront of reframing the psychedelic conversation. It has also remained committed to bringing science-backed benefits of psychedelics to the health industry, hence its position as a leading psychedelic wellness platform.

To offer insights into the company’s growth, Matt Stang, Delic’s co-founder and chief executive officer (“CEO”), appeared on The Jesse Tee Show, a growth-mindset broadcast whose aim is to teach anyone hunting greatness the secrets to success. The show highlights top entrepreneurs, athletes, thought leaders, and creators, who walk the audience through their stories and their path to success (https://ibn.fm/Fb5PW).

Mr. Stang touched on his professional background, highlighting how his senior thesis in college earned him an internship at High Times. This leading counterculture publication would later become the voice for the cannabis industry. Upon joining this enterprise, Mr. Stang became the director of its marketing and sales arm before buying the owner’s position in 2010 and becoming its driving force.

Mr. Stang then grew High Times into a $20 million a year business, an achievement that he attributed to “Understanding where opportunities and people connect, how to make things win-win for all people and giving them real value” (https://ibn.fm/Fb5PW).

Going on to become co-founder and CEO of Delic, headquartered in Vancouver, Stang and the company take pride in its comprehensive three-pronged ecosystem of Ketamine Wellness Centers (“KWC”), media properties, and DELIC Labs, a federally-authorized research facility. As of March 2022, the company had a market cap of $4.32 million, with a trailing 12-month (“TTM”) revenue of $3.6 million (https://ibn.fm/HaC3d).

The interview also touched on the therapeutic potential of psychedelic compounds. Mr. Stang was keen to note that Delic recognizes this potential and is capitalizing on it to create value for its shareholders while also offering a solution to individuals dealing with mental health conditions.

It is projected that by 2026, the psychedelic drugs market will be valued at $6.3 billion, up from $3.2 billion in 2021. This will represent a CAGR of 14.5%, mainly driven by regulatory support in the sector, widespread public awareness, and the overall growth in demand for psychedelic drug-assisted psychotherapy (https://ibn.fm/fTSah).

Delic realizes this opportunity, hence its investment in research and development (“R&D”) and its push to reframe the psychedelic conversation. The company has also been strategic with its acquisitions, having closed the purchase of Seattle-based Homestead Book Company back in 2021 in a move that sought to increase the company’s psychedelic media distribution.

Going forward, Delic looks to grow its intellectual property through more research. It also looks to provide education and high-quality products for the masses, particularly those struggling with mental health issues.

View the full interview at https://ibn.fm/Y5ge7.

For more information, visit the company’s website at www.DelicCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.